Evidence map›Paper›PMID 36094912›Full record

ArticlePloS one2022

Stopping syphilis transmission in Arctic communities through rapid diagnostic testing: The STAR study protocol.

Chelsea Caya, Mathieu Maheu-Giroux, Yiqing Xia, Bouchra Serhir, Veronique Morin, Michael Libman, Rachel Corsini, David M Goldfarb, Tom Wong, Ameeta E Singh and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 1 country.

Chelsea CayaResearch Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
Mathieu Maheu-GirouxDepartment of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, McGill University, Montreal, Quebec, Canada.ORCID 0000-0002-8363-4388
Yiqing XiaDepartment of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, McGill University, Montreal, Quebec, Canada.
Bouchra SerhirLaboratoire de Santé Publique du Québec /Institut National de Santé Publique du Québec, Sainte-Anne-de-Bellevue, Quebec, Canada.ORCID 0000-0003-0735-0452
Veronique MorinNunavik Regional Board of Health and Social Services, Kuujjuaq, Quebec, Canada.
Michael LibmanJD MacLean Centre for Tropical Diseases, McGill University Health Centre, Montreal, Quebec, Canada.
Rachel CorsiniResearch Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
David M GoldfarbBC Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
Tom WongIndigenous Services Canada, Government of Canada, Ottawa, Ontario, Canada.
Ameeta E SinghDepartment of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Cedric P YansouniResearch Institute of the McGill University Health Centre, Montreal, Quebec, Canada.ORCID 0000-0002-4765-3469
McGill University Health Centre · CAMcGill University · CAInstitut National de Santé Publique du Québec · CANunavik Regional Board of Health and Social Services · CAUniversity of Alberta · CAUniversity of British Columbia · CAUniversity of Toronto · CA

Funding

CIHR PJT-162262
6 · The paper itself

Abstract

backgroundIntense transmission of syphilis has emerged in some Canadian Arctic communities despite screening and prevention efforts. The remoteness of most communities and limited diagnostic infrastructure yield long delays (≥14 days) between screening and treatment of cases. These hamper syphilis control efforts and may contribute to sustained transmission. Syphilis rapid diagnostic tests (RDTs) have been developed to make screening more accessible and to inform clinical decision-making within the same clinical encounter. These RDTs have been successfully deployed in several countries, but not yet in Canada. METHODS AND

designWe describe the methodology of the "Stopping Syphilis Transmission in Arctic Communities Through Rapid Diagnostic Testing" (STAR) study, wherein the clinical and epidemiological impact of deploying a dual syphilis RDT in the context of ongoing transmission in Nunavut and Nunavik will be evaluated. In this prospective multisite field evaluation, sexually active individuals aged ≥14 years at risk for syphilis will be offered screening by an RDT at the point-of-care by non-laboratory trained registered nurses. Whole blood and serum specimens will be concurrently collected, when feasible, for rapid testing with an RDT containing both treponemal and non-treponemal components (Chembio DPP® Syphilis Screen & Confirm) and compared to laboratory-based reference testing according to a reverse sequence algorithm. The diagnostic accuracy of the RDT, using both whole blood and centrifuged serum specimens, will be validated under real-world conditions in remote Northern settings, outside of specialized laboratories. Additionally, screening-to-treatment time, case detection rates, and the number of infectious contacts averted by using the RDT relative to reference testing will be estimated. The impact of both diagnostic approaches on syphilis transmission dynamics will also be modeled. DISCUSSION: This study will provide much needed evidence for strengthening rapid responses to emerging syphilis outbreaks in remote Arctic regions, by supplementing traditional diagnostic strategies with an RDT to rapidly triage patients likely in need of treatment. These results will also inform the development and tailoring of future diagnostic strategies and public health responses to emerging outbreaks in the North.

Indexed as

SyphilisArctic RegionsCanadaHumansProspective StudiesSyphilis Serodiagnosis

Identifiers

PMID36094912
PMCPMC9467359
OpenAlexW4295429919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.